Connecting research to clinical realities

The articles included in this issue of the Journal of Hematology and Allied Sciences (Volume 5, Issue 3; September –December 2025) reflect the wide scope of modern hematology and its close integration with general clinical practice. Through a balanced mix of review articles, original research, and instructive case reports, this issue emphasizes the value of understanding disease mechanisms while remaining alert to rare or unusual clinical presentations.

The review by Sharma et al.^[1] on the autoimmune basis of acquired aplastic anemia provides a clear and timely summary of immune-mediated bone marrow failure. The authors describe how dysregulated T-cell activity and increased inflammatory signaling lead to the destruction of hematopoietic stem cells. This understanding supports the continued role of immunosuppressive therapy as a cornerstone of treatment and reinforces the importance of early recognition and appropriate disease classification to achieve better outcomes.

In an original research article, Garg et al.^[2] examine the potential usefulness of simple inflammatory markers such as the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with diabetic peripheral neuropathy. Their work highlights the growing interest in using routine laboratory parameters to identify and monitor systemic complications of chronic disease. The accessibility of these markers makes them particularly attractive for clinical practice, especially in settings where advanced investigations may not be readily available.

The importance of maintaining diagnostic vigilance is strongly reflected in the case reports featured in this issue. Rahul et al.^[3] document a case of bone marrow involvement by metastatic adenocarcinoma presenting with unexplained cytopenias. This report reminds clinicians that secondary marrow infiltration should remain an important differential diagnosis when routine evaluations fail to explain abnormal blood counts.

Similarly, Vinayak et al.^[4] present a challenging case of subcutaneous panniculitis-like T-cell lymphoma masquerading as benign panniculitis. The delay in diagnosis in this patient underscores the need for thorough pathological evaluation and immunohistochemistry in atypical or treatment-resistant cutaneous lesions. Such reports are valuable clinical reminders that rare malignancies can sometimes present in deceptively common forms.

A particularly striking contribution is the report by Nagpal et al.,^[5] describing twin sisters diagnosed with acute myeloid leukemia associated with a germline NPM1 mutation – the first such case documented from North India. This rare familial presentation broadens awareness of inherited susceptibility to myeloid malignancies and highlights the growing importance of germline genetic testing, patient counseling, and family screening in selected clinical contexts.

Extending beyond traditional hematology, Talukdar et al.^[6] review the use of pregnancy-specific biological substances in the management of chronic non-healing ulcers. Their article explores innovative therapeutic concepts rooted in physiological repair mechanisms and reflects the expanding interdisciplinary dialogue between hematology, pathology, and regenerative medicine.

Together, the contributions in this issue reflect the evolving landscape of our specialty, where advances in pathophysiology, genetics, and inflammation-related biomarkers translate directly into improved diagnostic and therapeutic strategies. The journal continues to serve as a platform for education, case-based learning, and academic discussion that reinforces the essential link between scientific research and everyday clinical decision-making.